SCHEMBL7715853

SCHEMBL7715853

Nc1ncc(Oc2ccc(F)cc2)c(N2CCN(c3ccccc3)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 7/20 0.50
HTR1A P08908 1/20 0.45
DRD2 P14416 1/20 0.45
HTR2A P28223 1/20 0.45
HRH1 P35367 1/20 0.45
DRD3 P35462 1/20 0.45
TMEM97 Q5BJF2 1/20 0.45
SIGMAR1 Q99720 1/20 0.45
MAPT P10636 3/20 0.45
TSHR P16473 2/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HRH4 Q9H3N8 1/20 0.43
TRPC6 Q9Y210 1/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712369 0.88 DHFR (0.50) DHFRHTR1ADRD2HTR2ADRD3
SCHEMBL7714124 0.85 MTOR (0.44) DHFRSMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL8156197 0.81 MEN1 (0.48) DHFRKMT2AMEN1MAPK1
SCHEMBL7714141 0.81 SCN9A (0.47) DHFRHTR1ADRD2HTR2AHRH1
SCHEMBL8123970 0.80 HTR1A (0.42) HTR1ADRD2HTR2AHRH1DRD3
SCHEMBL7714121 0.80 PIK3CA (0.55) DHFRTSHRHSD17B10POLB
SCHEMBL7708599 0.75 DRD4 (0.48) HTR1ASIGMAR1MAPTALDH1A1GAA
SCHEMBL7712448 0.74 MEN1 (0.46) MAPTTSHRALDH1A1SMN1; SMN2HSD17B10
SCHEMBL7714247 0.73 MEN1 (0.53) DHFRKMT2AMEN1
SCHEMBL7708416 0.73 HRH4 (0.55) DHFRHTR1ADRD2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed